SCHEMBL31284348

SCHEMBL31284348

O=c1cc(O)oc2c(Br)cc(F)cc12

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CSNK2A2 P19784 5/20 0.36
▸ CSNK2B P67870 5/20 0.36
▸ CSNK2A1 P68400 5/20 0.36
▸ NQO1 P15559 1/20 0.36
▸ SIRT2 Q8IXJ6 1/20 0.35
▸ GPR35 Q9HC97 5/20 0.33
▸ ESR2 Q92731 2/20 0.33
▸ ESR1 P03372 1/20 0.33
▸ GABRP O00591 4/20 0.33
▸ GABRD O14764 4/20 0.33
▸ GABRA1 P14867 4/20 0.33
▸ GABRB1 P18505 4/20 0.33
▸ GABRG2 P18507 4/20 0.33
▸ GABRB3 P28472 4/20 0.33
▸ GABRA5 P31644 4/20 0.33
▸ GABRA3 P34903 4/20 0.33
▸ GABRA2 P47869 4/20 0.33
▸ GABRB2 P47870 4/20 0.33
▸ GABRA4 P48169 4/20 0.33
▸ GABRE P78334 4/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31285059 0.79 SIRT2 (0.40) CSNK2A2CSNK2BCSNK2A1NQO1SIRT2
SCHEMBL31283819 0.79 ALDH1A1 (0.41) CSNK2A2CSNK2BCSNK2A1NQO1SIRT2
SCHEMBL27602177 0.79 GPR35 (0.56) CSNK2A2CSNK2BCSNK2A1GPR35
SCHEMBL23887043 0.72 SIRT2 (0.39) CSNK2A2CSNK2BCSNK2A1SIRT2GPR35
SCHEMBL4983007 0.71 GPR35 (0.58) GPR35
SCHEMBL31284139 0.70 SIRT2 (0.37) SIRT2LOXL2
SCHEMBL23887042 0.69 SIRT1 (0.33) NQO1ESR2ESR1
SCHEMBL27596275 0.68 SIRT2 (0.43) SIRT2LOXL2
SCHEMBL23887400 0.67 NQO1 (0.35) NQO1
SCHEMBL31035393 0.66 ALDH1A1 (0.33) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4731626-A1 PI3K INHIBITORS AND USE THEREOF Regor Pharmaceuticals, Inc. (US) 2026-04-29 — — EP disclosed
WO-2024260464-A1 PI3K INHIBITORS AND USE THEREOF REGOR PHARMACEUTICALS, INC. (US) 2024-12-26 — — WO disclosed
Send feedback